Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. (Q48035751)

7 February 2018

title

Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. (English)

1 reference

7 February 2018

main subject

multiple drug resistance

1 reference

1 reference

0 references

Alberto Lazarowski

1

1 reference

7 February 2018

Fabiana Lubieniecki

2

1 reference

7 February 2018

Sandra Camarero

3

1 reference

7 February 2018

Hugo Pomata

4

1 reference

7 February 2018

Marcelo Bartuluchi

5

1 reference

7 February 2018

Gustavo Sevlever

6

1 reference

7 February 2018

Ana Lía Taratuto

7

1 reference

7 February 2018

publication date

1 February 2004

1 reference

7 February 2018

published in

Pediatric Neurology

1 reference

7 February 2018

volume

30

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

102-106

1 reference

7 February 2018

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Cancer chemoresistance: the relationship between p53 and multidrug transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Neurologic manifestations of tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Tuberous sclerosis complex: a review of neurological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Surgical management and seizure outcome in patients with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

MDR1 gene expression in brain of patients with medically intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Regional expression of multidrug resistance genes in genetically epilepsy-prone rat brain after a single audiogenic seizure.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Malignant transformation of renal angiomyolipoma: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Biological behavior and tumorigenesis of subependymal giant cell astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

HIF-1 and tumor progression: pathophysiology and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900407-7

7 January 2021

10.1016/S0887-8994(03)00407-7

Identifiers

DOI

1 reference

7 February 2018

release_quevwicmondrjlp2qgqthbewea

Fatcat ID

0 references

PubMed ID

14984901

1 reference

7 February 2018